Artal Group S.A. - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 59 filers reported holding OMEGA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,446
-61.6%
2,533,0450.0%0.23%
-47.0%
Q2 2023$14,185
-7.1%
2,533,0450.0%0.44%
-51.5%
Q1 2023$15,274
+17.7%
2,533,045
+11.4%
0.91%
+25.2%
Q4 2022$12,982
-99.9%
2,273,5300.0%0.72%
+37.8%
Q3 2022$12,323,000
+42.6%
2,273,5300.0%0.53%
+14.1%
Q2 2022$8,639,000
-39.1%
2,273,5300.0%0.46%
-22.4%
Q1 2022$14,187,000
-44.9%
2,273,5300.0%0.59%
-15.0%
Q4 2021$25,759,000
-39.9%
2,273,5300.0%0.70%
-27.1%
Q3 2021$42,856,0002,273,5300.96%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 352,941$6,653,0008.31%
CHI Advisors LLC 1,055,882$19,904,0005.81%
Flagship Pioneering Inc. 25,902,269$488,258,0005.11%
HARBOURVEST PARTNERS LLC 2,647,059$49,897,0004.69%
Octagon Capital Advisors LP 370,279$6,980,0001.72%
Monashee Investment Management LLC 441,176$8,316,0001.54%
Artal Group S.A. 2,273,530$42,856,0000.96%
SPHERA FUNDS MANAGEMENT LTD. 527,948$9,952,0000.84%
PLATINUM INVESTMENT MANAGEMENT LTD 500,000$9,425,0000.26%
Logos Global Management LP 88,235$1,663,0000.12%
View complete list of OMEGA THERAPEUTICS INC shareholders